This content is machine translated Interview with Natalie Marcoli, MD “Personalized treatment in rheumatology would help even more patients achieve remission.” Achieving remission is the ultimate goal in the treatment of the inflammatory rheumatic diseases rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis [1-3]. In the following interview, Natalie Marcoli, MD, from…
View Post 8 min This content is machine translated Inflammatory rheumatic diseases Current data and expert opinions on the therapeutic goal of remission The management of inflammatory rheumatic diseases has improved significantly in recent years with the development of targeted treatments [1]. But how realistic is achieving remission today? The following report provides…
View Post 6 min This content is machine translated Type 2 diabetes: new ADA/EASD consensus report. Holistic treatment with a view to cardiorenal effects. The 2022 position paper of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) proposes to implement a holistic, multimodal treatment approach in the…
View Post 4 min This content is machine translated Therapy of type 2 diabetes in older age Avoid hypoglycemia and consider multimorbidity Over the past three decades, global diabetes prevalence has steadily increased, with an age-correlated increase in prevalence. Therapeutic goals in older type 2 diabetic patients differ from those of younger…
View Post 3 min This content is machine translated Diabetes Keeping an eye on weight: New insights in therapy management The global diabetes community met in Stockholm to benefit from the latest research and innovations in the field of diabetes. At the 58th Annual Meeting of the European Association for…
View Post 3 min This content is machine translated Diabetes mellitus type 1 Are there signs of autoimmune polyendocrine syndrome? Patients with type 1 diabetes have a higher risk of developing other autoimmune diseases. The autoimmune-related polyendocrine syndromes are rare but should be detected in time. Certain genetic mutations are…
View Post 9 min This content is machine translated Interview with Prof. Dr. med. Gerd Burmester “With the JAK inhibitors, we can get much more out of them for our patients” Oral Janus kinase inhibitors (JAKi) have been expanding the treatment landscape for inflammatory rheumatoid diseases for several years. In the following interview, Prof. Dr. med. Gerd Burmester explains what this…
View Post 4 min This content is machine translated Interactive expert Q&A session at the SGR Congress 2022 What you always wanted to know about JAK inhibitors Oral Janus kinase inhibitors (JAKi) are gaining ground in the treatment of inflammatory rheumatoid diseases and were therefore a hotly debated topic at this year’s annual congress of the Swiss…
View Post 4 min This content is machine translated Type 1 diabetes New insights into the development of autoimmune disease in children Study sheds light for the first time on the dynamics of blood glucose levels and autoimmunity in early childhood: When and why does type 1 diabetes manifest in children? For…
View Post 11 min This content is machine translated Interview on World Rheumatism Day “When those affected forget about the disease in their daily lives, it’s a particularly nice moment for us physicians.” Every year on October 12 is World Rheumatism Day. This was launched in 1996 by the international federation of self-help associations of rheumatism sufferers, “Arthritis and Rheumatism International (ARI)”. When…
View Post 4 min This content is machine translated AID systems Improved therapy for type 1 diabetes with new devices Increasingly, AID (Automated Insulin Delivery) systems are being used for automated or semi-automated insulin dosing in the treatment of type 1 diabetes. Through pump and sensor technology coupled with control…
